143 related articles for article (PubMed ID: 37036757)
1. Label-Free Physical-Analytical Techniques Reveal Epigenetic Modifications of Breast Cancer Chromosomes.
Agrawal T; Paul D; Saroj S; Ali A; Choubey V; Mukherjee D; Pal S; Rakshit T
J Phys Chem B; 2023 Apr; 127(15):3534-3542. PubMed ID: 37036757
[TBL] [Abstract][Full Text] [Related]
2. DNA methylation and repressive H3K9 and H3K27 trimethylation in the promoter regions of PD-1, CTLA-4, TIM-3, LAG-3, TIGIT, and PD-L1 genes in human primary breast cancer.
Sasidharan Nair V; El Salhat H; Taha RZ; John A; Ali BR; Elkord E
Clin Epigenetics; 2018; 10():78. PubMed ID: 29983831
[TBL] [Abstract][Full Text] [Related]
3. Loss of DNA methylation and histone H4 lysine 20 trimethylation in human breast cancer cells is associated with aberrant expression of DNA methyltransferase 1, Suv4-20h2 histone methyltransferase and methyl-binding proteins.
Tryndyak VP; Kovalchuk O; Pogribny IP
Cancer Biol Ther; 2006 Jan; 5(1):65-70. PubMed ID: 16322686
[TBL] [Abstract][Full Text] [Related]
4. DNA methylation profiling in breast cancer discordant identical twins identifies DOK7 as novel epigenetic biomarker.
Heyn H; Carmona FJ; Gomez A; Ferreira HJ; Bell JT; Sayols S; Ward K; Stefansson OA; Moran S; Sandoval J; Eyfjord JE; Spector TD; Esteller M
Carcinogenesis; 2013 Jan; 34(1):102-8. PubMed ID: 23054610
[TBL] [Abstract][Full Text] [Related]
5. Epigenetics in Metastatic Breast Cancer: Its Regulation and Implications in Diagnosis, Prognosis and Therapeutics.
Wu YS; Lee ZY; Chuah LH; Mai CW; Ngai SC
Curr Cancer Drug Targets; 2019; 19(2):82-100. PubMed ID: 29714144
[TBL] [Abstract][Full Text] [Related]
6. Aberrantly methylated DNA as a biomarker in breast cancer.
Kristiansen S; Jørgensen LM; Guldberg P; Sölétormos G
Int J Biol Markers; 2013; 28(2):141-50. PubMed ID: 23564623
[TBL] [Abstract][Full Text] [Related]
7. Epigenetics as a therapeutic target in breast cancer.
Connolly R; Stearns V
J Mammary Gland Biol Neoplasia; 2012 Dec; 17(3-4):191-204. PubMed ID: 22836913
[TBL] [Abstract][Full Text] [Related]
8. Current and upcoming approaches to exploit the reversibility of epigenetic mutations in breast cancer.
Falahi F; van Kruchten M; Martinet N; Hospers GA; Rots MG
Breast Cancer Res; 2014 Jul; 16(4):412. PubMed ID: 25410383
[TBL] [Abstract][Full Text] [Related]
9. Advances of Epigenetic Biomarkers and Epigenome Editing for Early Diagnosis in Breast Cancer.
Sarvari P; Sarvari P; Ramírez-Díaz I; Mahjoubi F; Rubio K
Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36076918
[TBL] [Abstract][Full Text] [Related]
10. Role of epigenetic modifications in luminal breast cancer.
Abdel-Hafiz HA; Horwitz KB
Epigenomics; 2015 Aug; 7(5):847-62. PubMed ID: 25689414
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic utility of epigenetics in breast cancer - A review.
Bhat SA; Majid S; Wani HA; Rashid S
Cancer Treat Res Commun; 2019; 19():100125. PubMed ID: 30802811
[TBL] [Abstract][Full Text] [Related]
12. The epigenetics of breast cancer.
Jovanovic J; Rønneberg JA; Tost J; Kristensen V
Mol Oncol; 2010 Jun; 4(3):242-54. PubMed ID: 20627830
[TBL] [Abstract][Full Text] [Related]
13. Epigenetics of Breast Cancer: Clinical Status of Epi-drugs and Phytochemicals.
Shukla S; Penta D; Mondal P; Meeran SM
Adv Exp Med Biol; 2019; 1152():293-310. PubMed ID: 31456191
[TBL] [Abstract][Full Text] [Related]
14. An integrated genomics analysis of epigenetic subtypes in human breast tumors links DNA methylation patterns to chromatin states in normal mammary cells.
Holm K; Staaf J; Lauss M; Aine M; Lindgren D; Bendahl PO; Vallon-Christersson J; Barkardottir RB; Höglund M; Borg Å; Jönsson G; Ringnér M
Breast Cancer Res; 2016 Feb; 18(1):27. PubMed ID: 26923702
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic mechanisms of breast cancer: an update of the current knowledge.
Karsli-Ceppioglu S; Dagdemir A; Judes G; Ngollo M; Penault-Llorca F; Pajon A; Bignon YJ; Bernard-Gallon D
Epigenomics; 2014; 6(6):651-64. PubMed ID: 25531258
[TBL] [Abstract][Full Text] [Related]
16. Aberrant Epigenetic Modifications of LPHN2 Function as a Potential Cisplatin-Specific Biomarker for Human Gastrointestinal Cancer.
Jeon MS; Song SH; Yun J; Kang JY; Kim HP; Han SW; Kim TY
Cancer Res Treat; 2016 Apr; 48(2):676-86. PubMed ID: 26511811
[TBL] [Abstract][Full Text] [Related]
17. Breast cancer: mechanisms involved in action of phytoestrogens and epigenetic changes.
Dagdemir A; Durif J; Ngollo M; Bignon YJ; Bernard-Gallon D
In Vivo; 2013; 27(1):1-9. PubMed ID: 23239847
[TBL] [Abstract][Full Text] [Related]
18. Early Epigenetic Markers for Precision Medicine.
Dumitrescu RG
Methods Mol Biol; 2018; 1856():3-17. PubMed ID: 30178243
[TBL] [Abstract][Full Text] [Related]
19. Epigenetics of breast cancer: Biology and clinical implication in the era of precision medicine.
Pasculli B; Barbano R; Parrella P
Semin Cancer Biol; 2018 Aug; 51():22-35. PubMed ID: 29339244
[TBL] [Abstract][Full Text] [Related]
20. Harnessing Epigenetics for Breast Cancer Therapy: The Role of DNA Methylation, Histone Modifications, and MicroRNA.
Szczepanek J; Skorupa M; Jarkiewicz-Tretyn J; Cybulski C; Tretyn A
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
